UniProt P84103
Serine/arginine-rich splicing factor 3 (P84103)
Serine/arginine-rich splicing factor 3 (UniProt P84103): 5 experimental structures and 1 predicted model on GenesisL1, 4 pockets. Binding sites, druggability and experiment against prediction (TM-score) in GL1X.
- UniProt
- P84103
- Protein
- Serine/arginine-rich splicing factor 3
- Experimental structures
- 5
- Predicted models
- 1
- Pockets
- 4 · 1 record with a druggable one
Structures
6 records of P84103 in the MolNFT archive: 5 experimental, 1 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 2I2Y | Solution structure of the RRM of SRp20 bound to the RNA CAUC | solution nmr | A | — | — |
| 2I2Y | Solution structure of the rrm of SRP20 bound to the RNA cauc | solution nmr | A | — | — |
| 2I38 | Solution structure of the RRM of SRp20 | solution nmr | A | — | — |
| 2I38 | Solution structure of the rrm of SRP20 | solution nmr | A | — | — |
| 9ASQ | Human Drosha, DGCR8 and SRSF3 in complex with Pri-let-7f1 | electron microscopy | H | — | 4 (best 0.85) |
| P84103 | AlphaFold monomer V2.0 prediction for SERINE/ARGININE-rich splicing factor 3 (P84103) | predicted | A | — | — |
Experiment against prediction
- 9ASQ chain H against the predicted model P84103: TM-score 0.87, RMSD 1.48 Å
- 2I2Y chain A against the predicted model P84103: TM-score 0.48, RMSD 2.58 Å
- 2I2Y chain A against the predicted model P84103: TM-score 0.48, RMSD 2.58 Å
- 2I38 chain A against the predicted model P84103: TM-score 0.47, RMSD 2.89 Å
- 2I38 chain A against the predicted model P84103: TM-score 0.47, RMSD 2.89 Å
- 2I2Y chain A against the predicted model P19909: TM-score 0.38, RMSD 3.54 Å
- 2I2Y chain A against the predicted model P19909: TM-score 0.38, RMSD 3.54 Å
- 2I38 chain A against the predicted model P19909: TM-score 0.38, RMSD 2.74 Å
- 2I38 chain A against the predicted model P19909: TM-score 0.38, RMSD 2.74 Å
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.